Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTSupporting their skin – and your treatment planPrescription Diet Derm Complete is formulated to support the skin barrier against environmental irritants, year round. + Tell Me More